: - Review the financial reports (quarterly financial report and annual audited financial report) to oversee that the reports are sufficient and correct before forwarding them to the Board of Directors for

: - Review the financial reports (quarterly financial report and annual audited financial report) to oversee that the reports are sufficient and correct before forwarding them to the Board of Directors for

positions, and oversee the executives’ and the management’s performance to optimize corporate efficiency and investors’ returns. Meanwhile, the shareholders have the right to be well-informed, make decisions

positions, and oversee the executives’ and the management’s performance to optimize corporate efficiency and investors’ returns. Meanwhile, the shareholders have the right to be well-informed, make decisions

positions, and oversee the executives’ and the management’s performance to optimize corporate efficiency and investors’ returns. Meanwhile, the shareholders have the right to be well-informed, make decisions

positions, and oversee the executives’ and the management’s performance to optimize corporate efficiency and investors’ returns. Meanwhile, the shareholders have the right to be well-informed, make decisions

USD 14,070,000, or equivalent to THB 485,544,756.67 (the “2nd Loan Portion”), where the Company shall be entitled to utilize the 2nd Loan Portion as capital expenditure, for business operation, as

Plant Capacity 1Q2018 1.5 million sq.ft /month 2Q2018 1.5 million sq.ft /month 3Q2018 1.7 million sq.ft /month 4Q2018 1.7 million sq.ft /month Table 7: Capital Expenditure (New Plant–Phase 3) CAPEX Budget

the tax benefit from capital expenditure in year 2016. Table2: Financial Summary for the six-month of year 2016 and 2017 Unit: Million Baht 1H’2017 1H’2016 Increase (Decrease) % Change Sales income

the tax benefit from capital expenditure in year 2016. Table2: Financial Summary for the six-month of year 2016 and 2017 Unit: Million Baht 1H’2017 1H’2016 Increase (Decrease) % Change Sales income